| Metric | Q4 2025 | Q3 2025 | Q4 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $3.9B | — | — | — | — |
| Op. Income | $507M | — | — | — | — |
| Gross Margin | 28.7% | — | — | — | — |
| Net Margin | 5.4% | — | — | — | — |
| EPS (Diluted) | $0.14 | — | — | — | — |
| Free Cash Flow | $549M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $3.9B |
| Cost of Revenue | $2.8B |
| GROSS PROFIT | $1.1B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $1.1B |
| SG&A Expenses | $1.1B |
| Other Expenses | -$442M |
| Operating Expenses | $622M |
| Cost & Expenses | $3.4B |
| OPERATING INCOME | $507M |
| Interest Income | $12M |
| Interest Expense | $300M |
| Other Income/Expenses | -$212M |
| INCOME BEFORE TAX | $295M |
| Income Tax Expense | $83M |
| Net Income from Continuing Ops | $212M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $213M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $213M |
| D&A | $1.6B |
| EBIT | $320M |
| EBITDA | $2.0B |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $3.9B |
| Cost of Revenue | $2.8B |
| GROSS PROFIT | $1.1B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $1.1B |
| SG&A Expenses | $1.1B |
| Other Expenses | -$442M |
| Operating Expenses | $622M |
| Cost & Expenses | $3.4B |
| OPERATING INCOME | $507M |
| Interest Income | $12M |
| Interest Expense | $300M |
| Other Income/Expenses | -$212M |
| INCOME BEFORE TAX | $295M |
| Income Tax Expense | $83M |
| Net Income from Continuing Ops | $212M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $213M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $213M |
| D&A | $1.6B |
| EBIT | $320M |
| EBITDA | $2.0B |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $213M |
| Depreciation & Amortization | $770M |
| Stock-Based Compensation | -$105M |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $127M |
| Change in Working Capital | -$180M |
| OPERATING CASH FLOW | $826M |
| Capital Expenditure | -$277M |
| Acquisitions (Net) | -$49M |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$175M |
| NET CASH FROM INVESTING | -$501M |
| Net Debt Issuance | $1.2B |
| Common Stock Repurchased | -$29M |
| Common Dividends Paid | -$302M |
| Other Financing Activities | -$566M |
| NET CASH FROM FINANCING | $255M |
| FREE CASH FLOW | $549M |
| Net Change in Cash | $580M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $1.9B |
| Short-Term Investments | $0 |
| Net Receivables | $3.1B |
| Inventory | $352M |
| Other Current Assets | $434M |
| TOTAL CURRENT ASSETS | $6.1B |
| PP&E (Net) | $12.8B |
| Goodwill | $7.6B |
| Intangible Assets | $14.9B |
| Long-Term Investments | $851M |
| Tax Assets | $0 |
| Other Non-Current Assets | $1.3B |
| TOTAL NON-CURRENT ASSETS | $37.4B |
| TOTAL ASSETS | $43.6B |
| Account Payables | $718M |
| Short-Term Debt | $2.9B |
| Deferred Revenue | $0 |
| Other Current Liabilities | $3.4B |
| TOTAL CURRENT LIABILITIES | $7.1B |
| Long-Term Debt | $20.1B |
| Deferred Revenue NC | $147M |
| Deferred Tax Liabilities | $3.1B |
| Other Non-Current Liabilities | $1.0B |
| TOTAL NON-CURRENT LIABILITIES | $24.4B |
| TOTAL LIABILITIES | $31.4B |
| Common Stock | $10.3B |
| Additional Paid-In Capital | $1.2B |
| Retained Earnings | $72M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $3M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $11.5B |
| Minority Interest | $588M |
| TOTAL EQUITY | $12.1B |
| TOTAL LIABILITIES & EQUITY | $43.6B |
| Total Debt | $23.0B |
| Net Debt | $21.1B |
